tiprankstipranks
Trending News
More News >
Aprea Therapeutics Inc (APRE)
NASDAQ:APRE
US Market

Aprea Therapeutics (APRE) Income Statement

Compare
486 Followers

Aprea Therapeutics Income Statement

Last quarter (Q3 2025), Aprea Therapeutics's total revenue was $1.85K, a decrease of -99.48% from the same quarter last year. In Q3, Aprea Therapeutics's net income was $-2.97M. See Aprea Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 1.50M$ 583.23K$ 0.00$ 0.00$ 0.00
Gross Profit
$ -7.86M$ 576.18K$ -16.40M$ -271.68K$ -229.61K
Operating Expenses
$ 6.46M$ 16.05M$ 96.99M$ 37.17M$ 52.81M
Depreciation and Amortization
$ 22.32K$ 7.05K$ 4.40K$ 271.68K$ 229.61K
EBITDA
$ -14.30M$ -14.28M$ -37.37M$ -36.86M$ -53.25M
Operating Income
$ -14.32M$ -15.47M$ -113.39M$ -37.45M$ -52.81M
Other Income/Expenses
$ 1.36M$ 1.19M$ 730.20K$ 319.05K$ -667.60K
Pretax Income
$ -12.96M$ -14.29M$ -112.66M$ -37.13M$ -53.48M
Net Income
$ -12.96M$ -14.29M$ -112.66M$ -36.54M$ -53.92M
Per Share Metrics
Basic EPS
$ -2.35$ -3.95$ -1.36K$ -34.88$ -50.61
Diluted EPS
$ -2.35$ -3.95$ -1.36K$ -34.88$ -50.61
Weighted Average Shares Outstanding
5.51M 3.62M 82.85K 1.06M 1.06M
Weighted Average Shares Outstanding (Diluted)
5.51M 3.62M 82.85K 1.06M 1.06M
Currency in USD

Aprea Therapeutics Earnings and Revenue History